0
Abstract: Poster Presentations |

TRANSFUSION PRACTICES IN PATIENTS UNDERGOING PROLONGED MECHANICAL VENTILATION AT A LONG-TERM ACUTE CARE HOSPITAL FREE TO VIEW

Heidi H. O Connor, MD*; Kelly Kirby; Alexander C. White, MD
Author and Funding Information

Tufts New England Medical Center, Boston, MA


Chest


Chest. 2007;132(4_MeetingAbstracts):562c-563. doi:10.1378/chest.132.4_MeetingAbstracts.562c
Text Size: A A A
Published online

Abstract

PURPOSE: A strategy of restrictive blood transfusion is accepted in the intensive care unit (ICU) setting. Optimal hemoglobin concentration for patients undergoing prolonged mechanical ventilation (PMV) is unknown. We evaluated hemoglobin replacement strategies in subjects undergoing prolonged mechanical ventilation (PMV).

METHODS: Chart review of red cell transfusion data in 135 subjects between March 1, 2002–February 28, 2003. Demographic and mechancial ventilation data has been previously reported in this cohort.

RESULTS: Twenty-seven percent (36/135) of subjects received red cell transfusions. Transfused subjects had lower hemoglobin (10.3±1.3 vs. 10.8±1.1 g/dl, p=0.04), lower serum albumin (2.0±0.5 versus 2.3±0.5 g/dl, p=0.008) and higher serum creatinine (1.29±0.7 versus 0.97±0.5 mg/dl, p=0.003) compared with non-transfused subjects. Subjects treated with epoetin alpha were more likely to receive a blood transfusion compared with those not receiving epoetin alpha (p=0.0007). Forty-seven percent (n=17) of transfused subjects required multiple red cell transfusions (range of red cell units transfused: 2–22) and had lower admission hemoglobin (9.9±1.3 versus 10.8±1.2 g/dl, p=0.04) and albumin (1.8±0.5 versus 2.2±0.3 g/dl, p=0.01) compared with those receiving a single red cell transfusion. There was no significant association between red cell transfusion and either ventilator associated pneumonia (p=0.12) or decannulation (p=0.15). There was a trend towards increased mortality in transfused subjects (p=0.06) compared with non-transfused subjects. Subjects undergoing transfusion had a longer length of stay (74 days, 45:158 vs. 49, 24:91, p=0.01, values expressed as median, first quartile:third quartile) and increased median cost of care ($62227, $30980:$128075 vs. $36036, $20297:$72668, p=0.04).

CONCLUSION: Subjects who received transfusions in an LTAC had significantly decreased hemoglobin, albumin, and renal function on admission compared with non-transfused subjects. Chronic critically ill subjects undergoing PMV required ongoing hemoglobin replacement, either in the form of erythropoetic agents or transfusions, and either treatment was associated with a longer length of stay and cost of care.

CLINICAL IMPLICATIONS: Evidence based practice guidelines are needed to assist in the use of hemoglobin replacement therapy in chronic critically ill patients undergoing prolonged mechanical ventilation.

DISCLOSURE: Heidi O Connor, No Financial Disclosure Information; No Product/Research Disclosure Information

Wednesday, October 24, 2007

12:30 PM - 2:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543